RYTM
RYTM
NASDAQ · Biotechnology

Rhythm Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$84.62
+2.03 (+2.46%)
As of Mar 25, 9:49 PM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 19 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target +19.5% upside
Low Target $80.78
Average Target $101.09
High Target $123.16
Current Price $84.62
Current
$84.62
Target
$101.09
$80.78 $101.09 avg $123.16
Scenario Analysis
Bear Case
$80.78
-4.5%
Low target
Base Case
$101.09
+19.5%
Avg target
Bull Case
$123.16
+45.5%
High target
Risk/Reward
10.0x
Highly favorable
Price in Context
52-Week High
$122.20
-30.8% from high
52-Week Low
$45.91
+84.3% from low
50-Day SMA
$105.86
-20.1% vs SMA
200-Day SMA
$92.90
-8.9% vs SMA
RSI (14)
49.1
Neutral
Target vs 52W High
$101.09
-17.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%